Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Should You Buy Roku Inc Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor
ROKU stock has already tripled since its IPO following a strong earnings report. Can the run continue, or will ongoing losses and rising competition cause Roku to fade to static?

Earnings Momentum Make Abbott Laboratories (ABT) a Buy

By Portfolio Grader
Abbott Laboratories (NYSE:ABT) is a member of the 161 company Health Care Equipment & Supplies GICS industry group, which is a segment of the 781 company GICS Health Care sector. ABT has a market value of $96.7 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for ABT puts it 31 among the 161 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 95 among the 781 companies in the sector, and number 606 in the nearly 5,000 company Portfolio Grader universe.

Banco Santander (SAN) a Buy on High-Level Sales Growth

By Portfolio Grader
As one of the 763 companies in the GICS Financials sector Banco Santander SA (NYSE:SAN) is a constituent of the 342 company Banks GICS industry group within this sector. The market value of SAN is $103.5 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for SAN puts it 82 among the 342 companies in this industry group, putting in the top quartile; in the top half of the sector with a ranking of 195 among the 763 companies in the sector, and number 1,241 in the nearly 5,000 company Portfolio Grader universe.

Strong Earnings Growth Keep Toronto-Dominion Bank (TD) a Buy

By Portfolio Grader
Toronto-Dominion Bank (NYSE:TD) is ranked as a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking TD has had from Portfolio Grader for the last month.

Earnings Momentum Metrics Restrict Medtronic (MDT) Ratings Upgrade to Hold

By Portfolio Grader
Medtronic Plc (NYSE:MDT) is ranked as a Hold using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Quant Score Makes Royal Bank of Canada (RY) a Buy

By Portfolio Grader
Royal Bank of Canada (NYSE:RY) is a component of the 342 company Banks GICS industry group, which is part of the 763 company GICS Financials sector. The market value of RY is $115.2 billion which falls in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 46 among the 342 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 113 among the 763 companies in the sector, and number 736 in the nearly 5,000 company Portfolio Grader universe.

Uninspiring Quant Score Hurt Citigroup (C) Rating

By Portfolio Grader
Citigroup Inc (NYSE:C) is a $188.6 billion in market value member of the Banks GICS industry group where Portfolio Grader's current ranking for C puts it 125 among the 342 companies in this industry group, putting it in the second quartile. C is ranked in the top half of the sector with a ranking of 292 among the 763 companies in the sector and number 1,854 in the 5000 company Portfolio Grader company universe.

Quant Score Keeps HSBC Holdings plc Sponsored ADR (HSBC) a Buy

By Portfolio Grader
HSBC Holdings plc Sponsored ADR (NYSE:HSBC) is classified as a constituent of the 342 company Banks GICS industry group, which is part of the 763 company GICS Financials sector. The market value of HSBC is $196.8 billion which falls in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 66 among the 342 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 161 among the 763 companies in the sector, and number 1,007 in the nearly 5,000 company Portfolio Grader universe.

Sinking Quant Score Keeps Wells Fargo & Co (WFC) a Sell

By Portfolio Grader
As one of the 763 companies in the GICS Financials sector Wells Fargo & Co (NYSE:WFC) is a member of the 342 company Banks GICS industry group within this sector. WFC's market value is $266.8 billion which falls in the top 10% of its industry group. The current Portfolio Grader ranking for WFC puts it 268 among the 342 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 602 among the 763 companies in the sector, and number 3,633 in the nearly 5,000 company Portfolio Grader universe.

Weak Quant Score Hurt Bank of America (BAC) Rating

By Portfolio Grader
Bank of America Corp (NYSE:BAC) is ranked as a Hold using Louis Navellier's investing system and his Portfolio Grader stock evaluator. BAC has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

JPMorgan Chase & Co (JPM) a Buy on Strong Quant Score

By Portfolio Grader
As one of the 763 companies in the GICS Financials sector JPMorgan Chase & Co (NYSE:JPM) is a component of the 342 company Banks GICS industry group within this sector. JPM has a market value of $340.5 billion which is in the top 10% of its industry group. The ranking for JPM by Portfolio Grader places it 98 among the 342 companies in this industry group, giving it an above-average position; in the top half of the sector with a ranking of 236 among the 763 companies in the sector, and number 1,500 in the nearly 5,000 company Portfolio Grader universe.

Pallid Earnings Growth Limits Berkshire Hathaway Energy (BRK.B) Rating

By Portfolio Grader
The current recommendation of Hold for Berkshire Hathaway Energy Co (NYSE:BRK.B) is derived using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Sales Growth Hurt Banco Santander Brasil (BSBR) Rating

By Portfolio Grader
With a $35,602.6 billion market value, Banco Santander Brasil SA (NYSE:BSBR) ranks in the top decile in its industry group, Banks, and in the top 10% of its sector group, Financials, in market value. From the viewpoint of investment attractiveness, the ranking for BSBR by Portfolio Grader places it 136 among the 342 companies in this industry group, giving it an above-average position; in the top half of the sector with a ranking of 315 among the 763 companies in the sector, and number 2,025 in the nearly 5,000 company Portfolio Grader universe.

3 Nagging Risks Netflix, Inc. Stock Investors Cannot Ignore

By Tom Taulli, InvestorPlace Contributor
It’s hard to argue with the strategy of Netflix. For the most part, the company is ideally positioned for the streaming megatrend. Yet there are still major risks.

Earnings Visibility Make MLP & Strategic Equity Fund (MTP) a Sell

By Portfolio Grader
Portfolio Grader currently ranks MLP & Strategic Equity Fund (NASDAQ:MTP) a Sell. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Vertex Pharmaceuticals’ (VRTX) Healthy Quant Score Make it a Buy

By Portfolio Grader
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is one of 349 companies within the Biotechnology GICS industry group, which is in turn part of the 781 company GICS Health Care sector. VRTX's market value is $37.2 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for VRTX puts it 60 among the 349 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 158 among the 781 companies in the sector, and number 1,038 in the nearly 5,000 company Portfolio Grader universe.

Regeneron Pharmaceuticals (REGN) a Hold on Poor Industry Group Rank

By Portfolio Grader
Portfolio Grader currently ranks Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a Hold. With proprietary fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. This represents no change from the previous week and is the same ranking REGN has had from Portfolio Grader for 5 months.

Cellect Biotechnology (APOP) a Buy on Robust Quant Score

By Portfolio Grader
The current recommendation of Buy for Cellect Biotechnology Ltd (NULL:APOP) is the result of using Louis Navellier's investing approach and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Earnings Growth Make Shire (SHPG) a Sell

By Portfolio Grader
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's investing system and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months.
Load More Articles